SPARC and metastatic malignant neoplasm: There is evidence for differential postranslational processing of SPARC in different cell types, potentially leading to differential functions [40], and it remains to be explored if this applies to non-neoplastic vs. neoplastic or non-metastatic vs. metastatic cancer cells.